Related references
Note: Only part of the references are listed.Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain
David W. Nelson et al.
JOURNAL OF LIPID RESEARCH (2011)
Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding
Chi-Liang Eric Yen et al.
NATURE MEDICINE (2009)
PAR-5359, a well-balanced PPARα/γ dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo
Mi-Kyung Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Raj S. Padwal et al.
LANCET (2007)
Properties of the mouse intestinal Acyl-CoA: monoacylglycerol acyltransferase, MGAT2
JS Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
CLE Yen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cloning and functional characterization of a mouse intestinal Acyl-CoA:monoacylglycerol acyltransferase, MGAT2
JS Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of acyl coenzyme A:Monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption
D Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase
CLE Yen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The expression of PPAR-associated genes is modulated through postnatal development of PPAR subtypes in the small intestine
K Mochizuki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
Share Paper
